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Prenatal diagnosis: What to tell the parents?
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The authors of the article “Prenatal Diagno-
sis of Facial Clefts: Evaluation of a Specialised
Counselling” [1] present an elegant study docu-
menting the favourable psychological effect of
prenatal diagnosis of this defect. Parents valued the
counselling, however unpleasant the initial mes-
sage. They welcomed the fact that they were pre-
pared at the birth for what was going to come 
and the security of an already arranged treatment 
pathway.
In general it can be stated that the beneficial
effects of this type of prenatal diagnosis of non-
acute disease are felt in a wide spectrum of congen-
ital diseases, such as omphalocele, gastroschisis,
renal disease, adenomatoid cystic disease of the
lung, and brain malformations. Forewarned par-
ents are prepared at birth and the acute shock of
discovery is cushioned; they are already acquainted
with the attending specialists and can enjoy the rel-
ative comfort of a well designed plan of campaign
for their child. The knowledge that there is treat-
ment available, and that all is not lost, is a highly
important factor in acceptance of the newborn’s
medical problem.
Prenatal diagnosis plays an even greater role 
in the diagnosis of acute life-threatening disease
such as severe congenital heart disease and brain
malformation. In this category there is always the
option of termination of the pregnancy, but, more
importantly, prenatal diagnosis may contribute to
a better overall outcome for the patient if the preg-
nancy is continued. Bonnet et al. have shown that
survival in transposition of the great arteries is
higher in the group with prenatal diagnosis, and
we have shown that a planned delivery in a centre
geared to the treatment of patients with congeni-
tal heart disease may ensure a better long-term
neurological outcome. Both facts can be attributed
to the better general preoperative condition of
these babies, and hypoxic lactacidosis can be pre-
vented by an immediate start with low-dose
prostaglandin and ventilatory support. This means
that the neonates arrive at surgical correction in
better condition and preoperative neurological
damage is minimised. This, and the obstetricians’
increased awareness of the anatomy of the 4-cham-
ber and long axis view of the foetal heart, has 
resulted, in the Lausanne region, in prenatal refer-
ral of 30% of all foetuses with congenital heart 
disease.
An encouraging sign is that the growing expe-
rience of obstetricians and perinatologists is re-
flected in the larger number of referrals for prena-
tal congenital abnormalities. In congenital heart
disease this is not the result of an increase in ma-
ternal indications (mother or sibling with congen-
ital heart disease, mother with diabetes or SLE,
toxic exposure of the mother), but of widening of
the foetal indications (presence of an organ or
chromosomal abnormality, foetal arrhythmia or
foetal hydrops, or hydramnion of unknown origin)
with the increased risk in the presence of a nuchal
translucency.
Finally, a remarkable fact in the article of
Hohlfeld et al. is that in two cases the referring ob-
stetrician did not tell the parents about the diag-
nosis of the congenital defect (facial cleft). In this
day and age one wonders whether this is a desir-
able policy. We feel strongly that if parents accept
and pay for prenatal evaluation of the foetus they
have the right to be informed and the attending
physician is under an obligation to inform them,
whether the news is good or bad. Hopefully 
this article, which highlights the positive aspects 
of prenatal diagnosis and information, may con-
tribute to full briefing of all parents of foetuses 
undergoing prenatal ultrasonographic evaluation. 
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